Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Arena Pharmaceuticals revenue
Arena Pharmaceuticals's revenue is $54,000.
What is Arena Pharmaceuticals's revenue?
- Arena Pharmaceuticals's revenue growth from 2009 to 2021 is -99.48%.
- Arena Pharmaceuticals has 194 employees, and the revenue per employee ratio is $278.
- Arena Pharmaceuticals's peak quarterly revenue was $801.1M in 2019(q1).
- Arena Pharmaceuticals peak revenue was $806.4M in 2019.
- Arena Pharmaceuticals annual revenue for 2020 was 319.0K, -99.96% growth from 2019.
- Arena Pharmaceuticals annual revenue for 2021 was 54.0K, -83.07% growth from 2020.
On this page
Zippi applies for you, and finds you a job.
Arena Pharmaceuticals historical revenue
Arena Pharmaceuticals's peak revenue was $806.4M in 2019. The peak quarterly revenue was $801.1M in 2019(q1).
Arena Pharmaceuticals's revenue increased from $10.4m in 2009 to $54.0K currently. That's a -99.48% change in annual revenue.
Arena Pharmaceuticals annual revenue
Arena Pharmaceuticals annual revenue over time
| Fiscal year / year | Arena Pharmaceuticals Revenue |
|---|---|
| 2009 | $10.4M |
| 2010 | $16.6M |
| 2011 | $12.7M |
| 2012 | $27.6M |
| 2013 | $81.4M |
| 2014 | $37.0M |
| 2015 | $13.4M |
| 2016 | $92.2M |
| 2017 | $21.3M |
| 2018 | $18.0M |
| 2019 | $806.4M |
| 2020 | $319,000 |
| 2021 | $54,000 |
Rate Arena Pharmaceuticals' financial transparency
Arena Pharmaceuticals annual growth
Arena Pharmaceuticals saw the greatest revenue growth in 2019, when revenue increased by 4,387.65%.
Arena Pharmaceuticals had the lowest revenue growth in 2020, when revenue changed by -99.96%.
Arena Pharmaceuticals annual growth rate over time
| Year | Arena Pharmaceuticals Growth |
|---|---|
| 2010 | 60%↑ |
| 2011 | -23%↓ |
| 2012 | 117%↑ |
| 2013 | 195%↑ |
| 2014 | -55%↓ |
| 2015 | -64%↓ |
| 2016 | 588%↑ |
| 2017 | -77%↓ |
| 2018 | -16%↓ |
| 2019 | 4388%↑ |
| 2020 | -100%↓ |
| 2021 | -83%↓ |
Arena Pharmaceuticals quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Arena Pharmaceuticals quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | - | - | - | $2.7M |
| 2010 | $2.5M | $2.5M | $7.6M | $4.0M |
| 2011 | $3.9M | $3.3M | $3.5M | $2.1M |
| 2012 | $2.2M | $22.0M | $1.5M | $1.9M |
| 2013 | $2.4M | $68.9M | $3.6M | $6.5M |
| 2014 | $6.8M | $12.8M | $8.2M | $9.2M |
| 2015 | $12.3M | $9.2M | $9.1M | ($17.2M) |
| 2016 | $9.8M | $9.5M | $19.2M | $53.6M |
| 2017 | $1.7M | $1.9M | $2.4M | $15.4M |
| 2018 | $1.8M | $4.0M | $3.6M | $8.6M |
| 2019 | $801.1M | $1.0M | $1.4M | $3.0M |
| 2020 | $262,000 | - | $20,000 | $37,000 |
Arena Pharmaceuticals Jobs Nearby
Do you work at Arena Pharmaceuticals?
Is Arena Pharmaceuticals transparent about its revenue structure?
Arena Pharmaceuticals financial information
| Company Type | Public |
| Employees Number | 194 |
| Date Founded | 1997 |
| Headquarters | San Diego, California |
| Number of Locations | 2 |
| Revenue | $54,000 |
| Net Income | -$616,433,000 |
| Gross Proft | $29.2M (2014) |
| PE Ratio | -4.00 |
| Tax Rate | -0.2% |
| Market Capitalization | $2.5B |
| Total Assets | $784,705,000 |
| Ticker | ARNA |
Arena Pharmaceuticals Jobs You Might Like
Arena Pharmaceuticals financing
Arena Pharmaceuticals received early financing of $35.0M on 2003-12-24.
| Series | Round size | Date |
|---|---|---|
| Series Unknown | $35M | 12/2003 |
| Post Ipo Equity | $151.8M | 06/2009 |
| Post Ipo Equity | $35.5M | 06/2010 |
| Post Ipo Equity | $33M | 01/2012 |
| Post Ipo Equity | $79.4M | 04/2017 |
| Post Ipo Equity | $56M | 10/2020 |
Arena Pharmaceuticals investors
| Investors | Security type |
|---|---|
| Deerfield | Post Ipo Equity |
| Deerfield Capital Management | Post Ipo Equity |
| Deerfield Capital Management | Post Ipo Equity |
| Farallon Capital Management | Post Ipo Equity |
Arena Pharmaceuticals competitors
Arena Pharmaceuticals's top competitor, Array BioPharma, earned an annual revenue of $173.8M.
Arena Pharmaceuticals's smallest competitor is Cellerant Therapeutics with revenue of $3.8M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| ZymoGenetics | - | $27.0M | 200 | - |
| Icagen | - | $14.1M | 47 | - |
| Array BioPharma | - | $173.8M | 298 | - |
| Ambrx | - | $7.4M | 80 | - |
| Tanabe Research Laboratories U.S.A | - | $64.0M | 50 | - |
| XBiotech | - | $4.0M | 56 | - |
| Agenus | - | $103.0M | 294 | - |
| Cellerant Therapeutics | - | $3.8M | 7 | - |
| Genocea | - | - | 59 | - |
| triusrx.com | - | $27.2M | 50 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Arena Pharmaceuticals highest paying jobs
Zippia gives an in-depth look into the details of Arena Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Arena Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Arena Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Arena Pharmaceuticals. The data presented on this page does not represent the view of Arena Pharmaceuticals and its employees or that of Zippia.
Arena Pharmaceuticals may also be known as or be related to ARENA PHARMACEUTICALS INC, Arena Pharm, Arena Pharmaceuticals, Arena Pharmaceuticals Inc and Arena Pharmaceuticals, Inc.